Safety & Performance Study of the Reliance 4-Front Lead

Status Completed

Clinical Trial Summary

The objective of this study is to gather data to establish the chronic safety, performance and effectiveness of the RELIANCE 4-FRONT™ Active Fixation Defibrillation Leads.

Clinical Trial Description

The RELIANCE 4-FRONT Defibrillation Lead Post Market Clinical Follow-Up Study is a prospective, non-randomized, multi-center, single-group, post market clinical study to establish the chronic safety, performance and effectiveness of the RELIANCE 4-FRONT active fixation defibrillation leads.

A total of 167 patients (including 10 % attrition) are required to evaluate the Primary Endpoint.

Up to 20 Investigational centers located in Europe and Asia Pacific. Lead-related Complication-Free Rate (CFR) from Implant through 3 Months Post-Implant.

Lead-related complications associated with the RELIANCE 4-FRONT active fixation lead will count toward this endpoint.

Lead-related Complication-Free Rate from 3 Months through 15 Months Post-Implant.

Lead-related complications associated with the RELIANCE 4-FRONT active fixation lead will count toward this endpoint.

- Lead-related Complication-Free Rate from 3 Months through 24 Months Post-Implant

- Pacing Threshold at 0.5 ms pulse width at 3 Months Post-Implant

- Sensed Amplitude at 3 Months Post-Implant

- Pacing Impedance at 3 Months Post-Implant All endpoints will be assessed for the RELIANCE 4-FRONT active fixation lead.

Clinic visits will occur at:

- Enrollment Visit (no later than 30 days prior to implant procedure)

- Implant Procedure (Day 0; all future follow ups based on this date)

- Pre-Discharge Clinic Visit (3 - 72 hours post-implant)

- One Month Clinic Visit (30±7 days)

- 3 Month Clinic Visit (91 ± 21 days)

- 6 Month Clinic Visit (180 ± 30 days)

- 12 Month Clinic Visit (365 ± 45 days)

- 18 Month Clinic Visit (545± 45 days)

- 24 Month Clinic Visit (730 ± 45 days) The study will be considered completed after all subjects have completed the 24 Month follow-up and study completion is anticipated in 2015. Primary endpoint completion is anticipated after all subjects have completed the 3 Month follow-up visit. All study required visits will be completed during clinic visits.

Hypotheses testing in the RELIANCE 4-FRONT PMCF Study will use standard statistical methodology as specified more in detail in the protocol. ;

Study Design

Related Conditions & MeSH terms

Tachycardia

Clinical Trial Details

NCT number	NCT01772576
Study type	Interventional
Source	Boston Scientific Corporation
Contact
Status	Completed
Phase	N/A
Start date	October 2012
Completion date	August 2016

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05649891` - Checklists Resuscitation Emergency Department	N/A
Withdrawn	`NCT05049720` - ExtraVascular Implantable Cardiac Defibrillator Continued Access Study	N/A
Completed	`NCT02941250` - Acute Defibrillation Performance of a Novel Can-less Shock Pathway	N/A
Completed	`NCT01592669` - Passive Leg Raising Attenuates and Delays Tourniquet Deflation-induced Hypotension and Tachycardia	N/A
Completed	`NCT00721136` - Randomized Study of the Use of Warfarin During Pacemaker or ICD Implantation in Patients Requiring Long Term Anticoagulation	N/A
Completed	`NCT04060680` - Extravascular ICD Pivotal Study	N/A
Recruiting	`NCT06048731` - Enlighten Study: The EV-ICD Post Approval Registry
Recruiting	`NCT04075084` - Observation of Clinical Routine Care for Patients With BIOTRONIK Implantable Cardiac Monitors (ICMs)
Completed	`NCT01410552` - Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination	N/A
Completed	`NCT00542854` - iPod and Other MP3 Players on ICDs and Pacemakers in Children	N/A
Completed	`NCT02877693` - A Post-market Clinical Evaluation of St. Jude Medical™ MR Conditional ICD System on Patients Undergoing Magnetic Resonance Imaging	N/A
Recruiting	`NCT06038123` - China 3T MRI Study	N/A
Completed	`NCT01754064` - St. Jude Medical Product Longevity and Performance (SCORE) Registry
Completed	`NCT00402246` - CONNECT Study - Clinical Evaluation Of Remote NotificatioN to rEduCe Time to Clinical Decision	N/A
Active, not recruiting	`NCT03940066` - Evaluation of Ambulatory Monitoring of Patients After High-risk Acute Coronary Syndrome Using Two Different Systems: Biomonitor-2 and Kardia Mobile	N/A
Completed	`NCT03012568` - Clinical Study to Confirm MRI Safety and Effectiveness Using St. Jude Medical (SJM) Cardiac Rhythm Management Systems
Completed	`NCT02772380` - Acute Study to Collect Electrical Signals From the Heart Using a Special Lead	N/A
Completed	`NCT01377051` - Effect of Indacaterol Maleate in Chronic Obstructive Pulmonary Disease (COPD) on Lung Volume and Related Dyspnea	Phase 4
Completed	`NCT00820625` - Long-Standing Persistant Atrial Fibrillation-Pulmonary Vein Isolation With or Without Ablation	N/A
Completed	`NCT03720639` - Confirm Rx™ Versus Reveal LINQ™ - Which is More Reliable in Data Transmission? A Randomized Clinical Study	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Safety and Performance Study of the Reliance 4-Front Lead

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms